Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Intestinal microbiota of red sea bream (Pagrus major)

PROVIDER: PRJNA856430 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20737005.fastq.gz	Fastqsanger.gz
	SRR20737006.fastq.gz	Fastqsanger.gz
	SRR20737007.fastq.gz	Fastqsanger.gz
	SRR20737008.fastq.gz	Fastqsanger.gz
	SRR20737009.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Intestinal microbiota of red sea bream (Pagrus major)

Project description:Intestinal microbiota of red sea bream (Pagrus major)

| PRJEB53722 | ENA

Effects of the nutritional background and parasite infection on the intestine transcriptome of gilthead sea bream, Sparus aurata

Project description:Gilthead sea bream fed plant-protein based diets with either fish oil or vegetable oil as the most iportant source of dietary lipids were experimentally exposed to the intestinal parasite Enteromyxum leei by water effluent. A specific gilthead sea bream oligo-microarray was used to determine the intestine transcriptomic response.

2012-10-16 | GSE35633 | GEO

Effects of the nutritional background and parasite infection on the intestine transcriptome of gilthead sea bream, Sparus aurata

2012-10-16 | E-GEOD-35633 | biostudies-arrayexpress

Pagrus major

Project description:Population genomes of red sea bream

| PRJNA578498 | ENA

Pagrus major

Project description:Pagrus major overview

| PRJNA427489 | ENA

Impact of the short chain fatty acid, sodium butyrate, on gut resident microbiota, gut mucus proteome and fish susceptibility to bacterial and parasitic infections in vivo

Project description:Previous works in the framework of EU ARRAINA Project evidenced a pro-inflammatory condition in gilthead sea bream (Sparus aurata) fed extremely low fish meal/fish oil diets, and this effect was mostly reversed by butyrate supplementation. The hypothesis of work is that these nutritionally-mediated changes can be extensive to intestinal mucus proteome and gut microbiota, which in turn could modify disease outcome.s If so, the prevalence and progression of the disease might be also modified by diet composition and feed additives. Gilthead sea bream fingerlings were fed with control and experimental diets formulated by BioMar until two year-old. FM was added at 25% in the control diet (D1) and at 5% in the other three diets (D2-D4). Added oil was either FO (D1 control diet) or a blend of vegetable oils, replacing the 58% (D2) and the 84% (D3-D4 diets) of FO. A commercial sodium butyrate preparation (NOREL, BP70) was added to the D4 diet at 0.4%. At month 20, 6 fish per each dietary treatment were sampled for iTRAQ profiling and fingerprinting of intestinal mucus proteome. Mucus collected from anterior and posterior intestine segments was trypsin digested, labelled with iTRAQ reagents, isoelectrofocused and resolved by LC-MS/MS. More than 1000 proteins were unequivocally annotated and principal component analysis clearly separated anterior and posterior segments. The diet effect with changes in the abundance of approximately 120 proteins was restricted to anterior section with a reversion of the pattern of the extreme diet (D3 fish) with dietary butyrate supplementation. Butyrate supplementation also reversed the decrease of microbiotay diversity associated with D3 feeding, and led to a improvement the disease outcomes in fish challenged with Photobacterium damselae and the intestinal parasite Enteromyxum leei.

2018-10-24 | PXD006183 | Pride

Pagrus major

Project description:Transparent phenotype of juvenile red sea bream

| PRJDB11031 | ENA

Pagrus major

Project description:Pagrus major genome analyses

| PRJDB5593 | ENA

Pagrus major

Project description:Pagrus major Genome sequencing

| PRJNA480768 | ENA

Transcriptome analysis of gilthead sea bream (Sparus aurata) brain after exposure to environmental concentrations of human pharmaceuticals

Project description:A gilthead sea bream (Sparus aurata) microarray platform was developed to identify brain gene expression profiles in response to environmental concentrations of human pharmaceuticals.

2014-05-22 | GSE38195 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data